The treatment of hypertension during pregnancy: When should blood pressure medications be started?

Current Cardiology Reports

Volumn 15, Issue 11, 2013, Pages

  Scantlebury, Dawn C ^a   Schwartz, Gary L ^a   Acquah, Letitia A ^a   White, Wendy M ^a   Moser, Marvin ^b   Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antihypertensive agents; Blood pressure medications; Cardiovascular diseases in women; Hypertension; Pregnancy induced; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LABETALOL; METHYLDOPA; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; SPIRONOLACTONE; ANTIHYPERTENSIVE AGENT;

ADVERSE OUTCOME; ARTICLE; BIRTH WEIGHT; CARDIOVASCULAR DISEASE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; ENDOTHELIAL DYSFUNCTION; FLUID RETENTION; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PERINATAL MORTALITY; PLASMA VOLUME; PREECLAMPSIA; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; RENOVASCULAR HYPERTENSION; SEDATION; SIDE EFFECT; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SOMNOLENCE; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; DRUG ADMINISTRATION; FEMALE; HEALTH CENTER; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; MATERNAL-CHILD HEALTH CENTERS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTERS; RISK FACTORS;

EID: 84886935137     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0412-0     Document Type: Article

References (62)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-22.
2. Dolea C, AbouZahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. In: Evidence and Information for Policy (EIP), World Health Organization. 2003. Available at: http://www.who.int/healthinfo/statistics/bod- hypertensivedisordersofpregnancy.pdf.
3. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of pre-eclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21:521-6. (Pubitemid 351589674)
4. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-74. doi: 10.1016/S0140-6736(06)68397-9.
5. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116:1302-9. doi: 10.1097/AOG.0b013e3181fdfb11.
6. • Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113:1299-306. doi: 10.1097/AOG.0b013e3181a45b25. This paper examines recent trends in the rates of HPD in the United States and immediate maternal morbidity.
7. Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis. 1974;16:363-74.
8. Curran-Everett D, Morris Jr KG, Moore LG. Regional circulatory contributions to increased systemic vascular conductance of pregnancy. Am J Physiol. 1991;261(6 Pt 2):H1842-7.
9. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54:2056-63. doi: 10.1046/j.1523-1755.1998.00217.x. (Pubitemid 28533634)
10. Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology. 1965;26:393-9.
11. Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: A review. Obstet Gynecol. 2000;96(5 Pt 2):849-60.
12. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101:669-74. (Pubitemid 24251519)
13. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93:1049-59. (Pubitemid 16004866)
14. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669-72. (Pubitemid 27446230)
15. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J Clin Invest. 2003;111:649-58. doi: 10.1172/JCI17189. (Pubitemid 36278583)
16. • Herse F, Lamarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reproduct Immunol. 2013;69:413-8. doi: 10.1111/aji.12072. This recent review summarizes evidence for the role of the AT1 receptor antibody in the pathogenesis of hypertensive pregnancy.
17. Wagner SJ, Craici IM, Grande JP, Garovic VD. From placenta to podocyte: Vascular and podocyte pathophysiology in pre-eclampsia. Clin Nephrol. 2012;78:241-9.
18. • Wagner SJ, Acquah LA, Lindell EP, Craici IM, Wingo MT, Rose CH, et al. Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clinic Proc. 2011;86:851-6. This report demonstrates that PRES and eclampsia may develop at relatively modest BP elevations, further emphasizing the need to readress the treatment targets in HPD guidelines.
19. Moser M. Historical perspectives on the management of hypertension. J Clin Hypertens. 2006;8(8 Suppl 2):15-20. quiz 39.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 2003;289:2560-72. doi: 10.1001/jama.289.19.2560. (Pubitemid 37430158)
21. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990;163(5 Pt 1):1691-712.
22. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2010;4:68-78. doi: 10.1016/j.jash.2010.03.002.
23. Redman CW. Hypertension in pregnancy: The NICE guidelines. Heart. 2011;97:1967-9. doi: 10.1136/heartjnl-2011-300949.
24. European Society of G, Association for European Paediatric C, German Society for Gender M, Authors/Task Force M, Regitz-Zagrosek V, Blomstrom Lundqvist C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147-97. doi: 10.1093/eurheartj/ehr218.
25. Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S, et al. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol. 2011;72:394-401.
26. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol. 1986;67:517-22. (Pubitemid 16116269)
27. •• Orbach H, Matok I, Gorodischer R, Sheiner E, Daniel S, Wiznitzer A, et al. Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol. 2012. doi: 10.1016/j.ajog.2012.11.011. This very recent report presents evidence for increasing fetal morbidity with chronic hypertension, regardless of treatment status.
28. Su CY, Lin HC, Cheng HC, Yen AM, Chen YH, Kao S. Pregnancy outcomes of antihypertensives for women with chronic hypertension: A population-based study. PLoS One. 2013;8:e53844. doi: 10.1371/journal.pone.0053844.
29. Ray JG, Vermeulen MJ, Burrows EA, Burrows RF. Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension In Pregnancy 2 (MOS HIP 2). BMC Pregnancy Childbirth. 2001;1:6. (Pubitemid 38729287)
30. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication vs methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162:960-6. discussion 6-7.
31. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007:CD002252. doi: 10.1002/14651858.CD002252.pub2 (Pubitemid 351820393)
32. • Ankumah N, Tita A, Cantu J, Chapman-Jauk V, Biggio J, Hauth J, et al. Pregnancy outcome vary by blood pressure level in women with mild-range chronic hypertension. Am J Obstet Gynecol. 2013;208:S261. Although only in abstract form, these data are based on the best characterized cohort of women with chronic hypertension in pregnancy and present important evidence of increased morbidity with mild to moderate hypertension in pregnancy.
33. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338:701-5. (Pubitemid 28115087)
34. Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: A review. Obstet Gynecol. 2000;96(5 Pt 2):849-60.
35. August P. Preeclampsia: New thoughts on an ancient problem. J Clin Hypertens. 2000;2:115-23.
36. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4:42-50.
37. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis. Lancet. 2000;355:87-92. (Pubitemid 30068551)
38. de Swiet M. Maternal blood pressure and birthweight. Lancet. 2000;355:81-2. doi: 10.1016/S0140-6736(99)00288-3. (Pubitemid 30068546)
39. Jannet D, Carbonne B, Sebban E, Milliez J. Nicardipine vs metoprolol in the treatment of hypertension during pregnancy: A randomized comparative trial. Obstet Gynecol. 1994;84:354-9. (Pubitemid 24267291)
40. Macones GA, Odibo A, Cahill A. Discussion: 'hypertension and antihypertensives in pregnancy,' by Orbach H, et al. Am J Obstet Gynecol. 2013. doi: 10.1016/j.ajog.2013.02.024.
41. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe pre-eclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246-54. (Pubitemid 40229437)
42. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500. (Pubitemid 26067737)
43. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: The effects of specific treatment on the growth and development of the children. Lancet. 1982;1:647-9. (Pubitemid 12179934)
44. Moser M, Brown CM, Rose CH, Garovic VD. Hypertension in pregnancy: Is it time for a new approach to treatment? J Hypertens. 2012;30:1092-100. doi: 10.1097/HJH.0b013e3283536319.
45. Schaefer C. Angiotensin II-receptor-antagonists: Further evidence of fetotoxicity but not teratogenicity. Birth defects research Part A. Clin Molec Teratol. 2003;67:591-4. doi: 10.1002/bdra.10081. (Pubitemid 37247675)
46. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443-51. doi: 10.1056/NEJMoa055202. (Pubitemid 43855047)
47. Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin- converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med. 1994;96:451-6. (Pubitemid 24156732)
48. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150:831-5. (Pubitemid 15237763)
49. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of pre-eclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J. 2008;156:918-30. doi: 10.1016/j.ahj.2008.06.042.
50. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944-51. doi: 10.1161/hypertensionaha.109.130765.
51. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ. 2007;335:974. doi: 10.1136/bmj.39335.385301.BE. (Pubitemid 350144670)
52. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet. 2005;366:1797-803. doi: 10.1016/s0140-6736(05)67726-4. (Pubitemid 41642644)
53. •• Ray JG, Schull MJ, Kingdom JC, Vermeulen MJ. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart. 2012;98:1136-41. doi: 10.1136/heartjnl-2011-301548. This very large population based study is the first to report the association between maternal placental syndromes, including pre-eclampsia, and an increased risk of HF and arrhythmias.
54. Campos O. Doppler Echocardiography during pregnancy: Physiological and abnormal findings. Echocardiography. 1996;13:135-46. (Pubitemid 26091363)
55. Savu O, Jurcut R, Giusca S, van Mieghem T, Gussi I, Popescu BA, et al. Morphological and functional adaptation of the maternal heart during pregnancy. Circulation Cardiovascular Imaging. 2012;5:289-97. doi: 10.1161/CIRCIMAGING.111. 970012.
56. Zanati Bazan SG, Borges VM, Martin LC, Magalhaes CG, Hueb JC, de Arruda Silveira LV, et al. Disproportionate pregnancy-induced myocardial hypertrophy in women with essential hypertension. Am J Hypertens. 2013. doi: 10.1093/ajh/hpt023.
57. • Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with pre-eclampsia at term. Hypertension. 2011;57:85-93. doi: 10.1161/ HYPERTENSIONAHA.110.162321. This studiy explores the effects of hypertensive pregnancy on maternal cardiac structure and function.
58. Ingec M, Yilmaz M, Gundogdu F. Left atrial mechanical functions in pre-eclampsia. J Obstet Gynaecol Res. 2005;31:535-9. doi: 10.1111/j.1447-0756. 2005.00332.x. (Pubitemid 43058182)
59. Melchiorre K, Sutherland GR, Watt-Coote I, Liberati M, Thilaganathan B. Severe myocardial impairment and chamber dysfunction in preterm pre-eclampsia. Hypertens Pregnancy. 2012;31:454-71. doi: 10.3109/10641955.2012.697951.
60. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58:709-15. doi: 10.1161/HYPERTENSIONAHA.111.176537.
61. • Strobl I, Windbichler G, Strasak A, Weiskopf-Schwendinger V, Schweigmann U, Ramoni A, et al. Left ventricular function many years after recovery from pre-eclampsia. BJOG. 2011;118:76-83. doi: 10.1111/j.1471-0528. 2010.02780.x. This is an echocardiographic study investigating the effect of hypertensive pregnancy on the maternal heart longterm.
62. •• Mannisto T, Mendola P, Vaarasmaki M, Jarvelin MR, Hartikainen AL, Pouta A, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681-90. doi: 10.1161/CIRCULATIONAHA.112.128751. This report demonstrates that all types of hypertensive pregancy, not only pre-eclampsia, are associated with longterm maternal cardiac morbidity, even in the absence of other known cardiovascular disease risk factors. This further underscores the impact of hypertension in pregnancy itself as a risk factor for CVD.